A Nomogram Combining MRI Multisequence Radiomics and Clinical Factors for Predicting Recurrence of High-Grade Serous Ovarian Carcinoma

Figure 3

DFS curves of patients with HGSOC in the overall cohort. (a) FIGO stage I-II vs. III-IV, . (b) Residual tumour status R0 vs. R1, . (c) PM absent vs. present, . (d) vs. >0.855, (e) Multi- vs. ≥-0.286, . (f) Pretreatment vs. ≥470.7, . (g) Primary treatment PDS+chemotherapy vs. NACT+IDS, . (h) Pretreatment vs. ≥385.0, . (i) Tumour composition cystic vs. solid vs. solid-cystic, .

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)